Navigation Links
Cellceutix Discovers Drug Activates 'Guardian Angel p53' in Fight Against Leukemia
Date:3/7/2011

ase contains forward-looking statements that are based on our current expectations, beliefs and assumptions about the industry and markets in which Cellceutix Corporation operates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause Cellceutix's actual results to be materially different from any future results expressed or implied by these statements. Actual results may differ materially from what is expressed in these statements, and no assurance can be given that Cellceutix can successfully implement its core business strategy and improve future earnings.

The factors that may cause Cellceutix's actual results to differ from its forward-looking statements include: Cellceutix's current critical need for additional cash to sustain existing operations and meet ongoing existing obligations and capital requirements; Cellceutix's ability to implement its new product development and commercialization, enter into clinical trials, expand the intellectual property portfolio, and receive regulatory approvals in a timely and cost-effective manner. All forward-looking statements are also expressly qualified in their entirety by the cautionary statements included in Cellceutix's SEC filings, including its quarterly reports on Form 10-Q and its annual report on Form 10-K.

Kevetrin, KM133, and KM-391 have not been studied in humans at this time. The Company's positive results in animal studies do not necessarily guarantee success in humans, though they may form the basis for beginning Phase 1 trials.


'/>"/>
SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Video: New Research Discovers Independent Brain Networks Control Human Walking
4. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
5. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
6. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
7. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
8. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
9. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
10. deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
11. deCODE Discovers Four New Risk Factors for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... IRVING, Texas , Jan. 15, 2014  Novation, the ... company, awarded several new IT value-added reseller (VAR) national ... with IT goods and services at lower costs. These ... value-added services such as initiative assistance and ongoing IT ...
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... SAN DIEGO, Feb. 27, 2012 Trovagene, Inc. (Pink ... announced that it has hired Leomics Associates, Inc. to ... high value intellectual property estate. "Trovagene ... with relevance for a broad array of clinical applications. ...
... 24, 2012  Nektar Therapeutics (Nasdaq: NKTR ) will ... 31, 2011 on Wednesday, February 29, 2012, after the close ... officer, will host a conference call to review the results ... (PT). The press release and a live ...
Cached Medicine Technology:Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 2Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 3Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets 2
(Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
(Date:4/17/2014)... New Rochelle, NY, April 17, 2014U.S. military personnel ... "blast plus impact" concussive traumatic brain injury (TBI) ... were evacuated for other medical reasons. Differences in ... and depression 6-12 months after injury are reported ... , a peer-reviewed journal from Mary Ann Liebert, ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... research team led by Cesar A. Arias, M.D., Ph.D., ... Houston (UTHealth) has identified a new superbug that caused ... appeared in the April 17 issue of The ... superbug is part of a class of highly-resistant bacteria ... which is a major cause of hospital and community-associated ...
(Date:4/17/2014)... 40 years away from a food shortage that will ... a top scientist at the U.S. Agency for International ... production will be limited on a global scale by ... Fred Davies, senior science advisor for the agency,s bureau ... destabilizing by 2050 as energy issues are today.", Davies, ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2
... treatments for heart disease, other conditions , MONDAY, Feb. ... that can change the way cells convert nutrients into ... heart attack, stroke and other conditions. , "Shifts in ... and in response to demanding activities -- like sprinting ...
... , Additional Grants and Donations Total ... and CLEARWATER, Fla. , Feb. 15 Catholic Health ... to support Global Health Ministry,s relief efforts in Haiti . ... use the funds to help rebuild the Hospital St. Francis de Sales ...
... , THE WOODLANDS, Texas , Feb. 15 ... the nation,s largest network including more than 1,300 oncologists and more than ... honored on Feb. 6 , by Texas Governor Rick Perry ... in El Paso, Texas . US Oncology was honored as an ...
... ... forum , ... February 14, 2010 -- Hayes, Inc., the nation’s leading health technology research and consulting ... Technology Research and Consulting, has joined the Medicare Evidence Development and Coverage Advisory Committee ...
... acyclovir is not a replacement for HIV-specific drugs, researchers say ... that people who are infected with both HIV-1, a strain ... could benefit in more than one way by taking a ... medication appears to also slow the progression of HIV. ...
... , , , , BEIJING , ... leading China -based vaccine manufacturer, today announced the completion by,its ... The total consideration for the purchase is approximately RMB120,million ... The,initial payment of RMB56.5 million ( $8.3 million ) ...
Cached Medicine News:Health News:Drugs That Shift Cell's Energy Find New Purpose 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 3Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 4Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 2Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 3Health News:Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 3
... steel work surface. Pneumatic ... to protect operator, as ... equipment from the workstation. ... for multiple vibration-free work ...
Perforated or Rod Top, Free Standing or Wall Mounted, Storage Cubby Optional, Polypropylene Construction...
... modular cleanroom for biological safety labs ... cleanliness (to Class 10/ISO 3) and ... create ultra-smooth surfaces that are easy ... radius corners simplify cleaning. Unique double-wall ...
Inquire...
Medicine Products: